What are the guidelines for prescribing long-acting reversible contraception (LARC) in adolescents?

Healthcare professionals should ensure that young people have access, without delay, to confidential, dedicated young people's contraceptive services that meet quality criteria, including offering a full range of contraceptive options such as LARC, and providing culturally appropriate, non-judgmental advice ².

When prescribing LARC to adolescent patients, healthcare professionals should take a relevant medical history, including menstrual, sexual, and family history, to assess medical eligibility, and exclude pregnancy before initiation ¹, ³.

In girls under 18, DMPA (depot medroxyprogesterone acetate) should only be considered if other methods are unsuitable or unacceptable, with review of risks and benefits at least every 2 years ¹, ³.

Informed consent should be obtained and documented, considering the young person's competence and understanding, in line with legal guidelines ¹, ², ³.

Healthcare professionals should be familiar with UK Medical Eligibility Criteria (UKMEC) categories to ensure safe prescribing, especially noting contraindications such as significant risk factors for osteoporosis or renal issues ¹, ³.